THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 127 filers reported holding THERAVANCE INC in Q3 2014. The put-call ratio across all filers is 1.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $2,383,000 | -26.3% | 80,009 | -23.5% | 0.52% | -30.1% |
| Q1 2014 | $3,235,000 | -33.1% | 104,545 | -22.9% | 0.74% | -30.5% |
| Q4 2013 | $4,834,000 | +83.3% | 135,583 | +110.1% | 1.07% | +55.1% |
| Q3 2013 | $2,637,000 | -58.2% | 64,528 | -60.6% | 0.69% | -61.5% |
| Q2 2013 | $6,304,000 | – | 163,617 | – | 1.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 20,395,056 | $607,365,000 | 9.89% |
| Realm Partners LLC | 301,521 | $8,979,000 | 3.75% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,805,837 | $83,558,000 | 2.52% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 7,447,743 | $221,794,000 | 2.27% |
| SECTORAL ASSET MANAGEMENT INC | 1,743,188 | $51,912,000 | 2.20% |
| Foundation Asset Management, LP | 255,790 | $7,617,000 | 2.19% |
| Proxima Capital Management, LLC | 550,000 | $16,379,000 | 1.93% |
| Roundview Capital LLC | 140,645 | $4,188,000 | 1.69% |
| BB BIOTECH AG | 933,244 | $27,792,000 | 1.32% |
| PERRY CAPITAL | 1,517,208 | $45,182,000 | 1.25% |